-
Orbit Genomics Has Been Selected For The Inaugural Cohort of Startups In CancerX’s Accelerator Program
We are thrilled to announce that Orbit Genomics has been selected for the inaugural cohort of startups in CancerX’s Accelerator program! CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot. A team of Accelerator Champions…
-
Orbit Genomics Named A Deep Tech Pioneer By Hello Tomorrow
We’re thrilled to announce we’ve been named a Deep Tech Pioneer by Hello Tomorrow! Out of an astonishing 4,500 applications from 120 countries, Orbit Genomics stood out as one of the most promising in the realm of deep tech. Come and meet us at the Hello Tomorrow Global Summit in March 2024, the cornerstone event…
-
Orbit Genomics Partners With Icahn School of Medicine at Mount Sinai
We are thrilled to announce that Orbit Genomics has partnered with the esteemed Icahn School of Medicine at Mount Sinai for optimization of our revolutionary lung cancer diagnostic platform. This collaboration will allow us to further advance the accuracy and reliability of our test, which will have significant implications for the future of cancer diagnosis…
